BrightSpring Health Services, Inc. BTSG
56.59
0.57
1.02%
as of 25 Sep
- Market cap
- $11.1B
- P/E
- 31.6×
Follow BTSG
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
38.96 | 28.03 | 39.84 | 46.19 |
+8 more quarters Free account |
P/S ratio |
1.00 | 0.64 | 0.59 | 0.50 | |
P/FCF ratio |
35.71 | 21.17 | 19.22 | 21.79 | |
P/Operating CF |
327.20 | 70.95 | 32.76 | 55.73 | |
P/B ratio |
7.01 | 4.41 | 4.05 | 3.31 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.11 | 0.76 | 0.78 | 0.69 | |
EV/EBITDA |
25.84 | 19.21 | 21.28 | 19.39 | |
EV/Operating CF |
31.64 | 20.22 | 20.44 | 24.06 | |
EV/FCF |
39.82 | 25.10 | 25.39 | 30.43 | |
Quick Ratio |
1.09 | 1.29 | 0.58 | 0.74 | |
Current Ratio |
1.59 | 1.74 | 1.57 | 1.79 | |
Net Debt/EBITDA |
9.46 | 9.93 | 16.17 | 18.16 | |
Debt/Assets |
36.82% | 40.41% | 39.33% | 41.78% | |
Debt/Equity |
1.08 | 1.27 | 1.35 | 1.39 | |
Asset Turnover |
2.41 | 2.26 | 2.09 | 2.05 | |
Operating CF/Net income |
0.52 | 0.83 | 3.00 | 1.93 | |
Capex/Depreciation |
(0.65) | (0.51) | (0.89) | (0.36) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.36% | 9.98% | 8.57% | 9.12% | |
Intangible Assets out of Total Assets |
0.51 | 0.49 | 0.48 | 0.48 | |
Share Based Compensation of Revenue |
0.50% | 0.10% | 0.40% | 0.52% | |
Graham Net Nets |
(0.10) | (0.18) | (0.22) | (0.24) | |
Graham Number |
20.01 | 18.18 | 13.99 | 11.34 | |
Earnings Yield |
2.57% | 3.57% | 2.51% | 2.17% | |
Free Cash Flow Yield |
2.80% | 4.72% | 5.20% | 4.59% | |
Revenue per Share |
18.80 | 17.65 | 17.53 | 16.38 | |
Operating CF per Share |
0.21 | 0.60 | 1.14 | 0.53 | |
Capex per Share |
(0.14) | (0.11) | (0.19) | (0.08) | |
Free Cash Flow per Share |
0.07 | 0.50 | 0.96 | 0.45 | |
Cash per Share |
2.67 | 4.34 | 0.44 | 0.69 | |
Shareholders Equity per Share |
9.94 | 9.67 | 9.26 | 8.94 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
9.94 | 9.67 | 9.26 | 8.94 | |
Free Cash Flow |
14.88 | 101.40 | 193.89 | 92.17 | |
Working Capital |
914.34 | 1,140.89 | 1,045.02 | 1,230.31 | |
Capital Expenditures |
(29.03) | (21.54) | (37.66) | (15.76) | |
Net Current Asset Value |
(1,466.96) | (1,544.63) | (1,644.12) | (1,450.56) | |
EV/EBIT |
35.78 | 28.27 | 33.94 | 34.62 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.00 | |
Net Profit Margin |
2.18% | 4.12% | 2.17% | 1.67% | |
Price to Operating Income |
32.09 | 23.84 | 25.69 | 24.79 | |
| Other line items | |||||
Average Receivables |
1,056.07 | 1,044.40 | 946.25 | 1,019.31 | |
Average Payables |
1,028.11 | 979.76 | 1,070.94 | 869.17 | |
Average Inventory |
600.24 | 546.90 | 725.87 | 558.76 | |
Average Assets |
5,964.66 | 6,030.13 | 6,169.73 | 5,917.73 | |
Average Common Equity |
1,895.70 | 1,833.31 | 1,761.50 | 1,716.81 |
Columns are period end dates